Who are Investigational varicella vaccine_Lot 2's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): MMR vaccination, varicella-5, Varicella Virus Vaccine Live, Stamaril, Sanofi Pasteur, Attenuated Hepatitis A Vaccine, H2 Strain, SKYVaricella®.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/investigational-varicella-vaccine-lot-2.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-18 · How we verify

Investigational varicella vaccine_Lot 2 — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Investigational varicella vaccine_Lot 2 (Investigational varicella vaccine_Lot 2) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Live attenuated vaccine. Area: Immunology / Infectious Disease.

phase 3 Live attenuated vaccine Varicella-zoster virus (VZV) glycoproteins Immunology / Infectious Disease Biologic Live · refreshed every 30 min

Target snapshot

Investigational varicella vaccine_Lot 2 (Investigational varicella vaccine_Lot 2) — GlaxoSmithKline. This vaccine stimulates the immune system to recognize and prevent varicella-zoster virus infection by inducing protective antibodies and cell-mediated immunity.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target
Investigational varicella vaccine_Lot 2 TARGET	Investigational varicella vaccine_Lot 2	GlaxoSmithKline	phase 3	Live attenuated vaccine	Varicella-zoster virus (VZV) glycoproteins
MMR vaccination	MMR vaccination	Klara M. Pósfay Barbe	marketed	Live attenuated vaccine
varicella-5	varicella-5	Changchun Keygen Biological Products Co., Ltd.	marketed	Live attenuated vaccine	Varicella-zoster virus
Varicella Virus Vaccine Live	Varicella Virus Vaccine Live	Sanofi Pasteur, a Sanofi Company	marketed	Live attenuated vaccine	Varicella-zoster virus (VZV)
Stamaril, Sanofi Pasteur	Stamaril, Sanofi Pasteur	Epicentre	marketed	Live attenuated vaccine	Yellow fever virus (17D strain)
Attenuated Hepatitis A Vaccine, H2 Strain	Attenuated Hepatitis A Vaccine, H2 Strain	Jiangsu Province Centers for Disease Control and Prevention	marketed	Live attenuated vaccine	Hepatitis A virus
SKYVaricella®	SKYVaricella®	SK Bioscience Co., Ltd.	marketed	Live attenuated vaccine	Varicella-zoster virus (VZV)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Live attenuated vaccine class)

GlaxoSmithKline · 19 drugs in this class
Merck Sharp & Dohme LLC · 11 drugs in this class
Sanofi Pasteur, a Sanofi Company · 9 drugs in this class
PATH · 5 drugs in this class
Sanofi · 5 drugs in this class
Bandim Health Project · 5 drugs in this class
Centers for Disease Control and Prevention · 3 drugs in this class
International Centre for Diarrhoeal Disease Research, Bangladesh · 3 drugs in this class
Beijing Center for Disease Control and Prevention · 2 drugs in this class
Aga Khan University · 2 drugs in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Investigational varicella vaccine_Lot 2 — Competitive Intelligence Brief. https://druglandscape.com/ci/investigational-varicella-vaccine-lot-2. Accessed 2026-05-18.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab